Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors

PURPOSE: Immune checkpoint inhibitors (ICIs) have shown durable responses in various malignancies. However, the response to ICI therapy is unpredictable, and investigation of predictive biomarkers needs to be improved. EXPERIMENTAL DESIGN: In total, 120 patients receiving ICI therapy and 40 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Chen, Wang, Mengyu, Gao, Quanli, Yuan, Shasha, Deng, Wenying, Bie, Liangyu, Ma, Yijie, Zhang, Chi, Li, Shuyi, Luo, Suxia, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813029/
https://www.ncbi.nlm.nih.gov/pubmed/35661905
http://dx.doi.org/10.1007/s00262-022-03221-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813029/
https://www.ncbi.nlm.nih.gov/pubmed/35661905
http://dx.doi.org/10.1007/s00262-022-03221-5

Ejemplares similares